Jan_Leschly.Com?
Executive Summary
During a Jan. 18 analysts briefing on the proposed Glaxo SmithKline merger, SmithKline Beecham CEO Jan Leschly used a question about the role of the Internet in pharmaceutical marketing to preview his plans for life after retiring from SB in April.
You may also be interested in...
Glaxo SmithKline Sees Consumer Internet Experience Helping Rx Strategy
Glaxo Wellcome is using the Internet to conduct virtual sales calls with physicians who refuse to see sales reps.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011